Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Generic Valganciclovir 450 mg vs Valcyte under Fed Conditions in Healthy Thai Volunteers
TCTR20220912001Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of valganciclovir (2 arms), sponsored by International Bio Service. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
valganciclovir
Beyond the preview
Go deeper on TCTR20220912001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220912001.